GRAM publications
Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
GBD 2021 Antimicrobial Resistance Collaborators None., (2024), Lancet, 404, 1199 - 1226
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Antimicrobial Resistance Collaborators None., (2022), Lancet, 399, 629 - 655
Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990-2019: a modelling study.
GRAM Typhoid Collaborators None., (2024), Lancet Glob Health, 12, e406 - e418
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
Antimicrobial Resistance Collaborators None., (2024), Lancet Glob Health, 12, e201 - e216
The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis.
Antimicrobial Resistance Collaborators None., (2023), Lancet Reg Health Am, 25
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Antimicrobial Resistance Collaborators None., (2022), Lancet, 400, 2221 - 2248
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.
European Antimicrobial Resistance Collaborators None., (2022), Lancet Public Health, 7, e897 - e913
Mapping local variation in household overcrowding across Africa from 2000 to 2018: a modelling study.
Chipeta MG. et al, (2022), Lancet Planet Health, 6, e670 - e681
Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.
Browne AJ. et al, (2021), Lancet Planet Health
The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria.
Dunachie SJ. et al, (2020), Curr Opin Microbiol, 57, 95 - 101
Recent publications by Researchers affiliated with the GRAM project
Mapping the global distribution of and environmental suitability for scrub typhus
Maude R. et al, (2025)
Recurrence of microfilaraemia after triple-drug therapy for lymphatic filariasis in Samoa: Recrudescence or reinfection?
Mayfield HJ. et al, (2025), Int J Infect Dis, 152
Integrated Serosurveillance of Infectious Diseases Using Multiplex Bead Assays: A Systematic Review.
Ward S. et al, (2025), Trop Med Infect Dis, 10
A systematic review of environmental covariates and methods for spatial or temporal scrub typhus distribution prediction.
Wang Q. et al, (2024), Environ Res, 263
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.
GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators None., (2024), Lancet Infect Dis, 24, 974 - 1002
Global and regional seroprevalence, incidence, mortality of, and risk factors for scrub typhus: a systematic review and meta-analysis.
Wang Q. et al, (2024), Int J Infect Dis
Evaluation of cancer screening services provided for people living with HIV in Botswana, 2022-2023.
Mathoma A. et al, (2024), Health Promot Int, 39
Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug mass drug administration.
Mayfield HJ. et al, (2024), PLoS Negl Trop Dis, 18
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Risk Factors Collaborators None., (2024), Lancet, 403, 2162 - 2203
Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990-2019: a modelling study.
GRAM Typhoid Collaborators None., (2024), Lancet Glob Health, 12, e406 - e418
Mastering geographically weighted regression: key considerations for building a robust model.
Kiani B. et al, (2024), Geospat Health, 19
Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study.
Sartorius K. et al, (2024), Int J Mol Sci, 25
Correction: Investigating risk factors for under-five mortality in an HIV hyper-endemic area of rural South Africa, from 2000-2014.
Tlou B. et al, (2024), PLoS One, 19
The Trends and Risk Factors of AIDS-Defining Cancers and Non-AIDS-Defining Cancers in Adults Living with and without HIV: A Narrative Review.
Mathoma A. et al, (2024), J Cancer Epidemiol, 2024
Spatial variations in STIs among women enrolled in HIV prevention clinical trials in Durban, KwaZulu-Natal, South Africa.
Dassaye R. et al, (2023), SAHARA J, 20
Using Regional Sero-Epidemiology SARS-CoV-2 Anti-S Antibodies in the Dominican Republic to Inform Targeted Public Health Response.
Mario Martin B. et al, (2023), Trop Med Infect Dis, 8
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance.
Cavany S. et al, (2023), Nat Commun, 14